Pfizer Gets CDSCO Panel Nod To Import 20 Valent Pneumococcal Conjugate Vaccine Dr. Divya Colin7 Dec 2024 5:45 PM ISTNew Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Full Immunization Coverage of country for FY 2023-24 stands at 93.23%: Health Ministry Kajal Rajput20 July 2024 1:45 PM ISTNew Delhi: There have been some media reports stating that in comparison to other countries, India has a high number of 'zero dose children' -...
Pneubevax 14 safe, immunogenic in 6-8 week old infants: Biological E Ruchika Sharma1 May 2024 2:20 PM ISTPNEUBEVAX 14 was found to be safe and induced robust and functional serotype specific immune responses to all 14 serotypes.
Navigating Pneumococcal Health: Insights Into Pneumococcal Conjugate Vaccination - Dr Pradeep Bajad Dr Pradeep Bajad15 April 2024 4:27 PM IST Pneumococcal disease in vaccinated individuals and in the population. Pneumococcal vaccination is indicated for adults with risk factors for...
Pfizer gets European Commission marketing nod for Prevenar 20 to protect infants, children against Pneumococcal Disease Susmita Roy14 March 2024 1:29 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for the company's 20-valent...
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Pfizer 20-Valent Pneumococcal Conjugate Vaccine for infants, children accepted by USFDA for Priority Review Ruchika Sharma8 Jan 2023 4:15 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental Biologics...
S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate Vaccine Ruchika Sharma17 Dec 2022 11:33 AM ISTBE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s...
PCV13 pneumococcal vaccine reduces risk of acute chest syndrome in kids with sickle cell anemia: JAMA Medha Baranwal11 Aug 2022 8:00 PM ISTFrance: Implementing a 13-valent pneumococcal conjugate vaccine (PCV13) in the general pediatric population may reduce the incidence of acute chest...
Merck presents positive results from Pneumococcal conjugate vaccine study Ruchika Sharma22 Jun 2022 2:30 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
Merck Pneumococcal vaccine gets USFDA Breakthrough Therapy Designation Ruchika Sharma16 April 2022 12:47 PM ISTThe Breakthrough Therapy Designation is an FDA program designed to expedite the development and review of products intended for serious or...
Pan India rollout of Pneumococcal Conjugate Vaccine will reduce child mortality by 60 percent: Health Minister MD Bureau31 Oct 2021 9:00 AM ISTNew Delhi: Union Health Minister Mansukh Mandaviya on Friday said the nationwide rollout of Pneumococcal Conjugate Vaccine (PCV) will reduce the child...
